ALURD (Allurion Technologies) PEG Ratio: N/A (As of Jun. 24, 2026)


ALURD Allurion Technologies Inc ALURD
16 GF Score
Price $5.91
GF Value $10.66
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Allurion Technologies PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Allurion Technologies's PE Ratio without NRI is 0.00. Allurion Technologies's 5-Year EBITDA growth rate is 0.00%. Therefore, Allurion Technologies's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Allurion Technologies's PEG Ratio or its related term are showing as below:



ALURD's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.95
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Allurion Technologies  (OTCPK:ALURD) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Allurion Technologies PEG Ratio Related Terms


Allurion Technologies PEG Ratio Historical Data

* Premium members only.

The historical data trend for Allurion Technologies's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allurion Technologies PEG Ratio Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
0.00 0.00 0.00 0.00 0.00

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ALURD vs ALRTF, VVOS, SINT: PEG Ratio Comparison

For the Medical Devices subindustry, Allurion Technologies's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allurion Technologies PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's PEG Ratio falls into.


ALURD
16GF Score
Allurion Technologies Inc ALURD
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allurion Technologies PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Allurion Technologies's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Allurion Technologies (ALURD) Overvalued in 2026?

Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued. The current stock price of $5.91 is trading 44.6% below its estimated GF Value™ of $10.66. GuruFocus considers Allurion Technologies to be Possible Value Trap.

Key valuation signals for ALURD:

  • PEG Ratio: N/A
  • GF Value™: $10.66 vs. price of $5.91 (44.6% below fair value)
  • GF Score™: 16/100 with 4 warning signs

No single metric tells the full story. See the ALURD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Allurion Technologies Business Description

Address 11 Huron Drive, Natick, MA, USA, 01760
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
16GF Score

Get the complete analysis for ALURD

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.91
Price
$10.66
GF Value